Utilizing Blockchain Technology to Improve Clinical Trials

Author:

Kumaresh Sakthi1,Sharma Neha2,Balu Priya Iyer Krishna1

Affiliation:

1. Department of Computer Science, M.O. P. Vaishnav College for Women, Chennai, India

2. Analytics and Insights, Tata Consultancy Services, Mumbai, India

Abstract

The development of new drugs by pharmaceutical companies becomes a challenging task as it takes longer timelines, and the clinical trial process involved before the introduction of any new drug is risky and highly unpredictable. The patient data available for the clinical trial process is distributed across several databases, and the data are stored in different formats; hence it becomes difficult to perform clinical trials. Many stakeholders (pharmaceutical companies, research labs, patients, participants, government authorities, and many more) across geography are involved in the clinical trial process. Cooperation among these stakeholders is necessary to conduct a clinical trial. A Clinical trial is a complex and time-consuming procedure that faces a constant challenge of data management, data sharing, and data security, resulting in being an expensive affair. Blockchain technology can be used to augment the entire workflow of clinical trials and overcome the mentioned challenges. It uses consensus protocol for efficient transmission and communication of data between nodes. Patient recruitment for clinical trials can be easily managed through “Smart contracts”. Any computational problem related to patient recruitment for a clinical trial, checking the validity of clinical trials, can be coded with smart contracts. This paper describes the utilization of blockchain to collect and store patient data and analysis results in a distributed yet secured manner, which can be shared in a transparent way and remain immutable as well as allows to tackle the challenges involved in the clinical trial process.

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference37 articles.

1. Van Dorn A.; COVID-19 and readjusting clinical trials. Lancet 2020 ,396(10250),523-524

2. Bhatt A.; Clinical trials during the COVID-19 pandemic: Challenges of putting scientific and ethical principles into practice. Perspect Clin Res 2020 ,11(2),59-63

3. COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: Globaldata. 2020 Available from: https://www.clinicaltrialsarena.com/comment/disruption-clinical-trial-oncology-covid-19/

4. COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData. Pharma Express 2020 Available from: https://www.expresspharma.in/covid-19-disrupted-clinical-trials-with-suspended-enrollment-more-likely-to-resume-globaldata/

5. Palombini M.; Driving innovation: blockchain adoption for clinical trials optimization. IEEE standards association 2020. Available from: https://www.clinicalleader.com/doc/driving-innovation-blockchain-adoption-for-clinical-trials-optimization-0001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3